Rice David V. 4

What Happened
David V. Rice, EVP — Clinical Operations & CMO of Community Health Systems (CYH), was granted three equity awards on 2026-06-01 totaling 90,000 shares (three grants of 30,000 each). Each grant shows an acquisition price of $0.00 (typical for restricted stock/RSU awards); no cash was paid. Two of the grants are reported as derivative awards (performance- or time-based RSUs); one appears as a direct restricted stock award subject to time-based vesting.

Key Details

• Transaction date: 2026-06-01; transaction code: A (award/grant). Report filed same day.
• Grants: 3 × 30,000 shares = 90,000 total; acquisition price $0.00; total reported value $0.
• Vesting notes:
  • One award vests in three equal time-based increments (1/3 on each of the first, second and third anniversaries) (F1).
  • One award is performance-based (2026–2028 performance period): 50% tied to cumulative same-store adjusted EBITDA growth and 50% to cumulative same-store net revenue growth; payout ranges 0%–200% of target and, if earned, vests on 3/1/2029 (F2).
  • The third award also vests in 1/3 increments on the first, second and third anniversaries (F3).
• Shares owned after the transaction were not specified in the provided filing.
• No 10b5-1 plan, tax withholding, sale, or cash exercise was indicated in the disclosed transactions.

Context
These awards are compensation grants (not open-market purchases or sales). Time-based RSUs vest over the next three years; the performance RSUs depend on multi-year corporate targets and could range from 0% to 200% of target. Such grants are routine executive compensation and do not by themselves indicate an immediate buy or sell signal.